Syndax Pharmaceuticals, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:SNDX) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 724.82 M640.71 M596.15 M551.79 M529.71 M472.67 M 負債合計 436.69 M425.65 M438.73 M436.36 M465.08 M431.05 M 純資産合計 288.12 M215.06 M157.42 M115.43 M64.63 M41.62 M 負債および純資産合計 724.82 M640.71 M596.15 M551.79 M529.71 M472.67 M 有利子負債合計 675.25 M————— 純負債 102.36 M—————

ニュース

Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Misses Revenue Estimates

Nuvation Bio Inc. (NUVB) Reports Next Week: Wall Street Expects Earnings Growth

Kura Oncology: Commercialization In AML Presents Asymmetric Upside (NASDAQ:KURA)

Syndax Pharmaceuticals, Inc. (SNDX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Syndax Pharmaceuticalsがバークレイズ会議で戦略的成長に焦点

Syndax Pharmaceuticals at Barclays Conference: Strategic Growth Focus

Leerink会議でのSyndax：戦略的成長と収益性への道筋

Syndax at Leerink Conference: Strategic Growth and Profitability

Syndax Pharmaceuticalsの株価が22.91ドルで52週高値を記録

Syndax Pharmaceuticals stock hits 52-week high at $22.91

TD Cowen会議でのSyndax：戦略的成長と財務力

Syndax at TD Cowen Conference: Strategic Growth and Financial Strength